Completed NA INTERVENTIONAL 1-arm NCT02441075

70% Ethanol for Decontamination of CVL Exposed to Calcineurine Inhibitors Version 1.0, 1/9/2014 (70% EtOH)

Sponsor: Daisy Foundation

Conditions GVHD Hematopoietic Stem Cell Transplant

Interventions 70% Ethanol

Updated 5 times since 2017 Last updated: Jan 28, 2016 Started: May 31, 2014 Primary completion: Jan 31, 2016 Completion: Jan 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02441075, this NA trial focuses on GVHD and Hematopoietic Stem Cell Transplant and remains completed. Sponsored by Daisy Foundation, it has been updated 5 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

May 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Daisy Foundation
Nationwide Children's Hospital

Data source: Nationwide Children's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Columbus, United States